News
Learn more about whether ADMA Biologics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...
Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.
Detailed price information for Centessa Pharmaceuticals Plc ADR (CNTA-Q) from The Globe and Mail including charting and trades.
4h
AlterNet on MSN'More trouble than she’s worth': Trump officials grow wary of Laura Loomer’s influence
Frustration is reportedly mounting inside the Trump administration as senior officials grow increasingly suspicious of ...
3h
Investor's Business Daily on MSNViking Therapeutics Crashes 42% On Mixed Results For Its Weight-Loss Pill
Viking Therapeutics stock crashed Tuesday — losing more than a third of its value — on mixed results for its weight-loss pill ...
The FDA said data for PTC's drug did not prove "substantial evidence of efficacy." Elsewhere, the FDA delayed its decision on ...
Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results